Dougherty & Co Upgrades Hologic (HOLX) to Buy; Pending GPRO Acquisition

July 31, 2012 9:33 AM EDT Send to a Friend
Get Alerts HOLX Hot Sheet
Price: $33.03 -0.42%

Rating Summary:
    12 Buy, 16 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 20 | Down: 22 | New: 30
Trade HOLX Now!
Join SI Premium – FREE
Dougherty & Co upgraded Hologic (NASDAQ: HOLX) from Neutral to Buy with a price target of $21.00 (from $20.00).

Analyst, Junaid Husain, said, "Following last night's Q3 results, we're upgrading HOLX to Buy ahead of the pending Aug 1st close of the Gen-Probe (Nasdaq: GRPO) acquisition...Ultimately, our Buy rating is predicated on solid execution of the Gen-Probe transaction."

For an analyst ratings summary and ratings history on Hologic click here. For more ratings news on Hologic click here.

Shares of Hologic closed at $18.26 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst PT Change, Mergers and Acquisitions, Upgrades

Add Your Comment